左心耳封堵预防心房颤动患者卒中的研究进展

doi:10.3969/j.issn.1673-5765.2019.05.013

摘要/Abstract

摘要：

预防心房颤动患者发生卒中的常用方法包括抗凝药物（华法林、新型口服抗凝药物等）及左心耳封堵（left atrial appendage occlusion，LAAO）治疗。近年来，一些研究表明LAAO在预防心房颤动患者卒中方面，不劣于华法林治疗，甚至在某些研究中优于华法林治疗，而关于LAAO与新型口服抗凝药对比的随机研究尚不充分。目前更新的文献提示，LAAO造成长期心房颤动患者相关门诊率和住院率升高，且可能对心房颤动的发生及发展产生一定影响，引起一些争议。这提示在临床实践中，重要的是严格把握手术适应证，综合长期获益与风险评估，准确判断适合进行LAAO的患者人群。

文章导读： 本文对左心耳封堵预防心房颤动患者卒中风险的有效性、安全性的相关研究结果和结论进行总结。

关键词: 心房颤动; 左心耳封堵; 缺血性卒中

Abstract:

Common methods for preventing stroke in patients with atrial fibrillation (AF) includes anticoagulant drugs, such as warfarin and new oral anticoagulants (NOAC), and left atrial appendage occlusion (LAAO). In recent years, some studies have shown that LAAO was not inferior to warfarin in the prevention of stroke in AF patients, and even better than warfarin, while randomized comparative studies of LAAO and NOAC are very few. However, the recent study suggested that LAAO increased the long-term AF-related outpatient care visit rate and hospitalization rate in AF patients, and might have an impact on the occurrence and development of AF, which brought some controversy. This suggested us that it is important to identify the indications of LAAO in clinical practice, and the patients suitable for LAAO should be strictly selected according to the comprehensive assessment of long-term benefit and risk.

Key words: Atrial fibrillation; Left atrial appendage occlusion; Ischemic stroke

张玮艺，黄光. 左心耳封堵预防心房颤动患者卒中的研究进展[J]. 中国卒中杂志, 2019, 14(05): 474-479.

ZHANG Wei-Yi, HUANG Guang. Progress in Prevention of Stroke in Patients with Atrial Fibrillation by Left Atrial Appendage Occlusion[J]. Chinese Journal of Stroke, 2019, 14(05): 474-479.

参考文献

[1] WHITLOCK R P，VINCENT J，BLACKALL M

H，et al. Left Atrial Appendage Occlusion Study II

（LAAOS II）[J]. Can J Cardiol，2013，29（11）：1443-

1447.

[2] JOHNSON W D，GANJOO A K，STONE C D，

et al. The left atrial appendage：our most lethal

human attachment! Surgical implications[J]. Eur J

Cardiothorac Surg，2000，17（6）：718-722. [3] MAHAJAN R，BROOKS A G，SULLIVAN T，

et al. Importance of the underlying substrate in

determining thrombus location in atrial fibrillation：

implications for left atrial appendage closure[J].

Heart，2012，98（15）：1120-1126.

[4] HEALEY J S，CONNOLLY S J，GOLD M R，et al.

Subclinical atrial fibrillation and the risk of stroke[J].

N Engl J Med，2012，366（2）：120-129.

[5] ALMAHAMEED S T，KHAN M，ZUZEK RW，

et al. Left atrial appendage exclusion and the risk

of thromboembolic events following mitral valve

surgery[J]. J Cardiovasc Electrophysiol，2007，18

（4）：364-366.

[6] KIRCHHOF P，AMMENTORP B，DARIUS H，

et al. Management of atrial fibrillation in seven

European countries after the publication of the

2010 ESC Guidelines on atrial fibrillation：primary

results of the PREvention of thromboemolic events-

-European Registry in Atrial Fibrillation（PREFER

in AF）[J]. Europace，2014，16（1）：6-14.

[7] YAO X，ABRAHAM N S，ALEXANDER G C，et

al. Effect of Adherence to Oral Anticoagulants on

Risk of Stroke and Major Bleeding Among Patients

With Atrial Fibrillation[J/OL]. J Am Heart Assoc，

2016. 5（2）. pii：e003074. https：//www.ahajournals.

org/doi/10.1161/JAHA.115.003074.

[8] PICCINI J P，SIEVERT H，PATEL M R，et al. Left

atrial appendage occlusion：rationale，evidence，

devices，and patient selection[J]. Eur Heart J，2017，

38（12）：869-876.

[9] GILLINOV A M. Advances in surgical treatment

of atrial fibrillation[J]. Stroke，2007，38（2 Suppl）：

618-623.

[10] YILMAZ A，VAN P，VAN W J，et al. Completely

thoracoscopic bilateral pulmonary vein isolation

and left atrial appendage exclusion for atrial

fibrillation[J]. J Thorac Cardiovasc Surg，2008，136

（2）：521-522.

[11] INOUE T，SUEMATSU Y. Left atrial appendage

resection can be performed minimally invasively

with good clinical and echocardiographic outcomes

without any severe risk[J]. Eur J Cardiothorac Surg，

2018，54（1）：78-83.

[12] LEE R，VASSALLO P，KRUSE J，et al. A

randomized，prospective pilot comparison of 3 atrial

appendage elimination techniques：internal ligation，

stapled excision，and surgical excision[J]. J Thorac

Cardiovasc Surg，2016，152（4）：1075-1080.

[13] HOLMES D R，REDDY V Y，TURI Z G，et al.

Percutaneous closure of the left atrial appendage

versus warfarin therapy for prevention of stroke in

patients with atrial fibrillation：a randomised noninferiority

trial[J]. Lancet，2009，374（9689）：534-

542.

[14] REDDY V Y，HOLMES D，DOSHI S K，et al.

Safety of percutaneous left atrial appendage closure：

results from the Watchman Left Atrial Appendage

System for Embolic Protection in Patients with AF

（PROTECT AF）clinical trial and the Continued

Access Registry[J]. Circulation，2011，123（4）：417-

424.

[15] HOLMES D R，KAR S，PRICE M J，et al.

Prospective randomized evaluation of the Watchman

Left Atrial Appendage Closure device in patients

with atrial fibrillation versus long-term warfarin

therapy：the PREVAIL trial[J]. J Am Coll Cardiol，

2014，64（1）：1-12.

[16] CONNOLLY S J，EZEKOWITZ M D，YUSUF S，et

al. Dabigatran versus warfarin in patients with atrial

fibrillation[J]. N Engl J Med，2009，361（12）：1139-

1151.

[17] PATEL M R，MAHAFFEY K W，GARG J，et al.

Rivaroxaban versus warfarin in nonvalvular atrial

fibrillation[J]. N Engl J Med，2011，365（10）：883-

891.

[18] CONNOLLY S J，EIKELBOOM J，JOYNER C，et

al. Apixaban in patients with atrial fibrillation[J]. N

Engl J Med，2011，364（9）：806-817.

[19] REDDY V Y，SIEVERT H，HALPERIN J，et

al. Percutaneous left atrial appendage closure vs

warfarin for atrial fibrillation：a randomized clinical

tria[J]. JAMA，2014，312（19）：1988-1998.

[20] REDDY V Y，DOSHI S K，KAR S，et al. 5-Year

outcomes after left atrial appendage closure：from

the PREVAIL and PROTECT AF Trials[J]. J Am

Coll Cardiol，2017，70（24）：2964-2975.

[21] REDDY V Y，MOBIUS-WINKLER S，MILLER

M A，et al. Left atrial appendage closure with the

Watchman device in patients with a contraindication

for oral anticoagulation：the ASAP study（ASA

Plavix Feasibility Study With Watchman Left Atrial

Appendage Closure Technology）[J]. J Am Coll

Cardiol，2013，61（25）：2551-2556.

[22] GANGIREDDY S R，HALPERIN J L. FUSTER V，

et al. Percutaneous left atrial appendage closure for

stroke prevention in patients with atrial fibrillation：

an assessment of net clinical benefit[J]. Eur Heart J，

2012，33（21）：2700-2708.

[23] SAHAY S，NOMBELA-FRANCO L，RODESCABAU

J，et al. Eficacy and safety of left atrial

appendage closure versus medical treatment in

atrial fibrillation：a network meta-analysis from randomisedtrials[J]. Heart，2017，103（2）：139-147.

[24] OSMANCIK P，TOUSEK P，HERMAN D，et

al. Interventional left atrial appendage closure vs

novel anticoagulation agents in patients with atrial

fibrillation indicated for long-term anticoagulation

（PRAGUE-17 study）[J/OL]. Am Heart J，2017，

183：108-114. doi：10.1016/j.ahj.2016.10.003.

https：//linkinghub.elsevier.com/retrieve/pii/

S0002870316302150.

[25] TZIKAS A，SHAKIR S，GAFOOR S，et al. Left

atrial appendage occlusion for stroke prevention in

atrial fibrillation：multicentre experience with the

AMPLATZER Cardiac Plug[J]. Euro Intervention，

2016，11（10）：1170-1179.

[26] YAO X，GERSH B J，HOLMES D R，et al.

Association of surgical left atrial appendage

occlusion with subsequent stroke and mortality

among patients undergoing cardiac surgery[J].

JAMA，2018，319（20）：2116-2126.

[27] HOIT B D，SHAO Y，TSAI L M，et al. Altered

left atrial compliance after atrial appendectomy.

Influence on left atrial and ventricular filling[J]. Circ

Res，1993，72（1）：167-175.

[28] DAVIS C A，REMBERT J C，GREENFIELD J

C. Compliance of left atrium with and without left

atrium appendage[J/OL]. Am J Physiol，1990，259

（4 Pt 2）：H1006-H1008. https：//doi.org/10.1152/

ajpheart.1990.259.4.H1006.

[29] YAMANAKA K，SEKINE Y，NONAKA M，

et al. Left atrial appendage contributes to left

atrial booster function after the maze procedure：

quantitative assessment with multidetector computed

tomography[J]. Eur J Cardiothorac Surg，2010，38

（3）：361-365.

[30] LEINONEN J V，EMANUELOV A K，PLATT Y，et

al. Left atrial appendages from adult hearts contain

a reservoir of diverse cardiac progenitor cells[J/

OL]. PLoS One，2013，8（3）：e59228. doi：10.1371/

journal.pone.0059228. https：//journals.plos.org/

plosone/article?id=10.1371/journal.pone.0059228.

[31] MASOUDI F A，CALKINS H，KAVINSKY C J，et

al. 2015 ACC/HRS/SCAI Left Atrial Appendage

Occlusion Device Societal Overview：a professional

societal overview from the American College of

Cardiology，Heart Rhythm Society，and Society for

Cardiovascular Angiography and Interventions[J].

Catheter CardiovascInterv，2015，86（5）：791-807.